echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > J INTERN MED: Higher levels of autoantibodies against apoB100 p210 are associated with lower incidence of atrial fibrillation in women

    J INTERN MED: Higher levels of autoantibodies against apoB100 p210 are associated with lower incidence of atrial fibrillation in women

    • Last Update: 2021-09-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Atrial fibrillation (AF) is associated with inflammation of the whole body and atrial tissue
    .
    The level of oxidized LDL in patients with AF increases, and it is considered to be one of the important molecules that cause inflammation


    .


    Recently, an authoritative journal in the field of internal medicine published a research article in the Journal of Internal Medicine.
    Researchers explored the correlation between autoantibodies against oxidized apolipoprotein B100 peptide and the incidence of AF in a large population-based cohort
    .

    The researchers measured the IgM and IgG levels of the natural and aldehyde-modified apoB100 peptides 210 (p210) and 45 in the plasma of 5169 participants from the Malmö diet and cancer cohort by ELISA
    .

    During the 21.
    3-year follow-up period, the researchers recorded a total of 769 AF events
    .
    Individuals with higher IgM levels for natural p210 at baseline had a lower risk of AF, but this association did not persist after adjusting for age and gender


    .


    Thus, these results support the association between self-body fluid immunity and atrial fibrillation
    .

    These results support the association between body fluid immunity and atrial fibrillation
    .
    immunity

    Original source:

    Original source:

    Kari Anne Sveen.


    et al.


    High levels of autoantibodies against apoB100 p210 are associated with lower incidence of atrial fibrillation in women in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.